Market Analysis and Insights: Global Custom Compounded Therapy Market
The global Custom Compounded Therapy market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Custom Compounded Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Custom Compounded Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Custom Compounded Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Custom Compounded Therapy include Fagron, Specialist Pharmacy, Nova Laboratories, Athenex Pharma Solutions, ImprimisRx, Fresenius Kabi, Baxter, B. Braun and Galenic Laboratories, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Custom Compounded Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Custom Compounded Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Custom Compounded Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Custom Compounded Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Custom Compounded Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Custom Compounded Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Fagron, Specialist Pharmacy, Nova Laboratories, Athenex Pharma Solutions, ImprimisRx, Fresenius Kabi, Baxter, B. Braun and Galenic Laboratories, etc.
By Company
Fagron
Specialist Pharmacy
Nova Laboratories
Athenex Pharma Solutions
ImprimisRx
Fresenius Kabi
Baxter
B. Braun
Galenic Laboratories
Pencol Compounding Pharmacy
McKesson Corporation
Clinigen Group
Segment by Type
Drug Customization
Meal Customization
Rehabilitation Customization
Other
Segment by Application
Hospital
Family
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Custom Compounded Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Custom Compounded Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Compounded Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Custom Compounded Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Drug Customization
1.2.3 Meal Customization
1.2.4 Rehabilitation Customization
1.2.5 Other
1.3 Market by Application
1.3.1 Global Custom Compounded Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Family
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Custom Compounded Therapy Market Perspective (2018-2029)
2.2 Global Custom Compounded Therapy Growth Trends by Region
2.2.1 Custom Compounded Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Custom Compounded Therapy Historic Market Size by Region (2018-2023)
2.2.3 Custom Compounded Therapy Forecasted Market Size by Region (2024-2029)
2.3 Custom Compounded Therapy Market Dynamics
2.3.1 Custom Compounded Therapy Industry Trends
2.3.2 Custom Compounded Therapy Market Drivers
2.3.3 Custom Compounded Therapy Market Challenges
2.3.4 Custom Compounded Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Custom Compounded Therapy by Players
3.1.1 Global Custom Compounded Therapy Revenue by Players (2018-2023)
3.1.2 Global Custom Compounded Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Custom Compounded Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Custom Compounded Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Custom Compounded Therapy Market Concentration Ratio
3.4.1 Global Custom Compounded Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Custom Compounded Therapy Revenue in 2022
3.5 Global Key Players of Custom Compounded Therapy Head office and Area Served
3.6 Global Key Players of Custom Compounded Therapy, Product and Application
3.7 Global Key Players of Custom Compounded Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Custom Compounded Therapy Breakdown Data by Type
4.1 Global Custom Compounded Therapy Historic Market Size by Type (2018-2023)
4.2 Global Custom Compounded Therapy Forecasted Market Size by Type (2024-2029)
5 Custom Compounded Therapy Breakdown Data by Application
5.1 Global Custom Compounded Therapy Historic Market Size by Application (2018-2023)
5.2 Global Custom Compounded Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Custom Compounded Therapy Market Size (2018-2029)
6.2 North America Custom Compounded Therapy Market Size by Type
6.2.1 North America Custom Compounded Therapy Market Size by Type (2018-2023)
6.2.2 North America Custom Compounded Therapy Market Size by Type (2024-2029)
6.2.3 North America Custom Compounded Therapy Market Share by Type (2018-2029)
6.3 North America Custom Compounded Therapy Market Size by Application
6.3.1 North America Custom Compounded Therapy Market Size by Application (2018-2023)
6.3.2 North America Custom Compounded Therapy Market Size by Application (2024-2029)
6.3.3 North America Custom Compounded Therapy Market Share by Application (2018-2029)
6.4 North America Custom Compounded Therapy Market Size by Country
6.4.1 North America Custom Compounded Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Custom Compounded Therapy Market Size by Country (2018-2023)
6.4.3 North America Custom Compounded Therapy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Custom Compounded Therapy Market Size (2018-2029)
7.2 Europe Custom Compounded Therapy Market Size by Type
7.2.1 Europe Custom Compounded Therapy Market Size by Type (2018-2023)
7.2.2 Europe Custom Compounded Therapy Market Size by Type (2024-2029)
7.2.3 Europe Custom Compounded Therapy Market Share by Type (2018-2029)
7.3 Europe Custom Compounded Therapy Market Size by Application
7.3.1 Europe Custom Compounded Therapy Market Size by Application (2018-2023)
7.3.2 Europe Custom Compounded Therapy Market Size by Application (2024-2029)
7.3.3 Europe Custom Compounded Therapy Market Share by Application (2018-2029)
7.4 Europe Custom Compounded Therapy Market Size by Country
7.4.1 Europe Custom Compounded Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Custom Compounded Therapy Market Size by Country (2018-2023)
7.4.3 Europe Custom Compounded Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Custom Compounded Therapy Market Size (2018-2029)
8.2 China Custom Compounded Therapy Market Size by Type
8.2.1 China Custom Compounded Therapy Market Size by Type (2018-2023)
8.2.2 China Custom Compounded Therapy Market Size by Type (2024-2029)
8.2.3 China Custom Compounded Therapy Market Share by Type (2018-2029)
8.3 China Custom Compounded Therapy Market Size by Application
8.3.1 China Custom Compounded Therapy Market Size by Application (2018-2023)
8.3.2 China Custom Compounded Therapy Market Size by Application (2024-2029)
8.3.3 China Custom Compounded Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Custom Compounded Therapy Market Size (2018-2029)
9.2 Asia Custom Compounded Therapy Market Size by Type
9.2.1 Asia Custom Compounded Therapy Market Size by Type (2018-2023)
9.2.2 Asia Custom Compounded Therapy Market Size by Type (2024-2029)
9.2.3 Asia Custom Compounded Therapy Market Share by Type (2018-2029)
9.3 Asia Custom Compounded Therapy Market Size by Application
9.3.1 Asia Custom Compounded Therapy Market Size by Application (2018-2023)
9.3.2 Asia Custom Compounded Therapy Market Size by Application (2024-2029)
9.3.3 Asia Custom Compounded Therapy Market Share by Application (2018-2029)
9.4 Asia Custom Compounded Therapy Market Size by Region
9.4.1 Asia Custom Compounded Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Custom Compounded Therapy Market Size by Region (2018-2023)
9.4.3 Asia Custom Compounded Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Custom Compounded Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Custom Compounded Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Custom Compounded Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Fagron
11.1.1 Fagron Company Details
11.1.2 Fagron Business Overview
11.1.3 Fagron Custom Compounded Therapy Introduction
11.1.4 Fagron Revenue in Custom Compounded Therapy Business (2018-2023)
11.1.5 Fagron Recent Developments
11.2 Specialist Pharmacy
11.2.1 Specialist Pharmacy Company Details
11.2.2 Specialist Pharmacy Business Overview
11.2.3 Specialist Pharmacy Custom Compounded Therapy Introduction
11.2.4 Specialist Pharmacy Revenue in Custom Compounded Therapy Business (2018-2023)
11.2.5 Specialist Pharmacy Recent Developments
11.3 Nova Laboratories
11.3.1 Nova Laboratories Company Details
11.3.2 Nova Laboratories Business Overview
11.3.3 Nova Laboratories Custom Compounded Therapy Introduction
11.3.4 Nova Laboratories Revenue in Custom Compounded Therapy Business (2018-2023)
11.3.5 Nova Laboratories Recent Developments
11.4 Athenex Pharma Solutions
11.4.1 Athenex Pharma Solutions Company Details
11.4.2 Athenex Pharma Solutions Business Overview
11.4.3 Athenex Pharma Solutions Custom Compounded Therapy Introduction
11.4.4 Athenex Pharma Solutions Revenue in Custom Compounded Therapy Business (2018-2023)
11.4.5 Athenex Pharma Solutions Recent Developments
11.5 ImprimisRx
11.5.1 ImprimisRx Company Details
11.5.2 ImprimisRx Business Overview
11.5.3 ImprimisRx Custom Compounded Therapy Introduction
11.5.4 ImprimisRx Revenue in Custom Compounded Therapy Business (2018-2023)
11.5.5 ImprimisRx Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Custom Compounded Therapy Introduction
11.6.4 Fresenius Kabi Revenue in Custom Compounded Therapy Business (2018-2023)
11.6.5 Fresenius Kabi Recent Developments
11.7 Baxter
11.7.1 Baxter Company Details
11.7.2 Baxter Business Overview
11.7.3 Baxter Custom Compounded Therapy Introduction
11.7.4 Baxter Revenue in Custom Compounded Therapy Business (2018-2023)
11.7.5 Baxter Recent Developments
11.8 B. Braun
11.8.1 B. Braun Company Details
11.8.2 B. Braun Business Overview
11.8.3 B. Braun Custom Compounded Therapy Introduction
11.8.4 B. Braun Revenue in Custom Compounded Therapy Business (2018-2023)
11.8.5 B. Braun Recent Developments
11.9 Galenic Laboratories
11.9.1 Galenic Laboratories Company Details
11.9.2 Galenic Laboratories Business Overview
11.9.3 Galenic Laboratories Custom Compounded Therapy Introduction
11.9.4 Galenic Laboratories Revenue in Custom Compounded Therapy Business (2018-2023)
11.9.5 Galenic Laboratories Recent Developments
11.10 Pencol Compounding Pharmacy
11.10.1 Pencol Compounding Pharmacy Company Details
11.10.2 Pencol Compounding Pharmacy Business Overview
11.10.3 Pencol Compounding Pharmacy Custom Compounded Therapy Introduction
11.10.4 Pencol Compounding Pharmacy Revenue in Custom Compounded Therapy Business (2018-2023)
11.10.5 Pencol Compounding Pharmacy Recent Developments
11.11 McKesson Corporation
11.11.1 McKesson Corporation Company Details
11.11.2 McKesson Corporation Business Overview
11.11.3 McKesson Corporation Custom Compounded Therapy Introduction
11.11.4 McKesson Corporation Revenue in Custom Compounded Therapy Business (2018-2023)
11.11.5 McKesson Corporation Recent Developments
11.12 Clinigen Group
11.12.1 Clinigen Group Company Details
11.12.2 Clinigen Group Business Overview
11.12.3 Clinigen Group Custom Compounded Therapy Introduction
11.12.4 Clinigen Group Revenue in Custom Compounded Therapy Business (2018-2023)
11.12.5 Clinigen Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Fagron
Specialist Pharmacy
Nova Laboratories
Athenex Pharma Solutions
ImprimisRx
Fresenius Kabi
Baxter
B. Braun
Galenic Laboratories
Pencol Compounding Pharmacy
McKesson Corporation
Clinigen Group
*If Applicable.